The Neuro-Ophthalmology program at Weill Cornell Medicine Ophthalmology serves patients with neurologic and systemic disorders that affect vision and eye movements, such as cerebrovascular disease, migraine, demyelination, thyroid disease, myasthenia, and other auto-immune disease. The program provides diagnosis and treatment for patients with double vision, blurred vision, transient or permanent loss of vision, or unusual visual phenomena. Special therapeutic strategies are available to assist patients recovering from double vision and visual field loss resulting from trauma, stoke, or neurosurgical procedures. Botulinum toxin therapy (BOTOX®) is available for patients diagnosed with blepharospasm or hemifacial spasm.
The Neuro-Ophthalmology Service is directed by Dr. Marc Dinkin, an expert in diagnosis and management of vascular disorders affecting vision.